# Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)

> **NCT00598624** · PHASE2 · UNKNOWN · sponsor: **IRCCS San Raffaele** · enrollment: 175 (estimated)

## Conditions studied

- Leukemia
- Chronic Myeloid Leukemia
- Myelodysplastic Syndrome
- Diffuse Large Cell Lymphoma
- Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Multiple Myeloma

## Interventions

- **DRUG:** Treosulfan IV

## Key facts

- **NCT ID:** NCT00598624
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2009-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598624, "Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00598624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*